Novo Nordisk and Lilly shares are trading lower amid circulation of a report suggesting a link between Ozempic and higher risk of a serious eye condition.
Portfolio Pulse from Benzinga Newsdesk
Novo Nordisk and Eli Lilly shares are trading lower due to a report suggesting a link between Ozempic and a higher risk of a serious eye condition.
July 03, 2024 | 3:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly shares are trading lower due to a report linking Ozempic to a higher risk of a serious eye condition.
The report suggesting a link between Ozempic and a serious eye condition could negatively impact investor sentiment and lead to a decline in Eli Lilly's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Novo Nordisk shares are trading lower following a report linking Ozempic to a higher risk of a serious eye condition.
The report suggesting a link between Ozempic and a serious eye condition could negatively impact investor sentiment and lead to a decline in Novo Nordisk's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100